FDA Investigator Paul L Bellamy

Paul L Bellamy has conducted inspections on 368 sites in 27 countries as of 07 Aug 2017. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
368
Last Inspection Date:
07 Aug 2017
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, Jordan, China, Taiwan, Philippines, Germany, Australia, France, Italy, Poland, Canada, Austria, Norway, India, Singapore, Japan, Spain, Denmark, Puerto Rico, Israel, United Kingdom of Great Britain and Northern Ireland, Netherlands, Finland, Malta, Mexico, Portugal, Korea (Republic of)
FDA Investigators that have inspected at least one site in common with Paul L Bellamy:
Abdur Rafay Shareef, Addam S Reynolds, Adetutu M Gidado, Aditi S Thakur, Agnes M Santori, Aimee Cunningham, PhD, Alberto A Viciedo, Alice S Tsao, Alicia M Mozzachio, Allen Lou, Almaris N Alonso, Amatul H Marium, Amber G Wardwell, Amy Chen, Amy L Singer, Amy M Codella, Amy M Cramer, Amy N Chen, Ana S Cabrera, Anders W Evenson, Anh M Lac, Anita R Michael, Anjali Shukla, PhD, Ankur C Patel, Ann Marie Montemurro, Ann Marie Schofield, Anna M Brannen, Annemarie B Randow, Annemarie Bodnar, Annet R Rajan, Anthony A Charity, Anthony C Warchut, Anthony J Donato, Antoinette L Ravelli, Arie C Menachem, Ariel Cruz Figueroa, Arsen Karapetyan, Ashley J Burns, Ashutosh Rao, PhD, Asia D Clark, Atul J Agrawal, Azeezat M Lawal, Azza Talaat, Barbara J Maulfair, Barbara Janine Breithaupt, Barbara Jwilimczyk Macri, Barbara L Rellahan, PhD, Bei Yu, Bijoy Panicker, Bo Chi, PhD, Brenda P King, Brenda Rivera, Brenda S Zimmer, PhD, Brenda W Uratani, PhD, Brian D Nicholson, Brian R Yaun, Bruce H Mccullough, Bryan J Love, Byungja E Marciante, Cara M Minelli, Carl A Huffman, III, Carla J Lundi, Carlos A Medina, Carrie L Doupnik, Cary Greene, Cassandra L Abellard, Chad E Schmear, Chaoying C Ma, Charisse K Green, Charles D Brown, Charles I Ann, Charles J Chacko, Charles M Edwards, Charles R Cote, RIC, Charles Yuanchia Kuo, PhD, Charlotte Hinkle, Charlotte P Chang, Cheryl A Clausen, Cheryl A Grandinetti, Chiang Syin, PhD, Christian F Gomez Lugo, Christina A Miller, Christina K Theodorou, Christina N Maurino, Christina P Burkhart, Christine M Cerenzio, Christopher D Leach, Christopher R Czajka, Christopher T Middendorf, Concepcion Cruz, Jr, Constantin Y Philopoulos, Craig D Zagata, Cynthia F Kleppinger, MD, Cynthia Jim, CSO, Cynthia Whitmarsh, Dan Grabicki, Daniel J Grabicki, Daniel J Lahar, Daniel J Min, Daniel L Zheng, Darin S Wiegers, Darren S Morgan, David A Oluwo, David E Bailey, David J Hafner, Dawn L Wydner, Dayna I Martinez, Deborah A Greco, Deborah B Goffman, Deborah B Nixon, Deborah Schmiel, PhD, Debra L Pagano, Demitria J Xiradakis, Denise M Visco, Investigator, Dennis Cantellops Paite, Dennis L Doupnik, Derek S Dealy, Devaughn Edwards, Devon Jenkins, Deyaa Shaheen, Dhaval H Patel, Dinesh Kumar, Dipesh K Shah, Don H Bark, PhD, Donald C Obenhuber, PhD, Donald L Lech, Dongping Dai, PhD, Doreen P Canetti, Doreen P Gubbay, Dorothy J Denes, Douglas A Campbell, Douglas C Kovacs, Dr. Barbara D Paul, PhD, Dr. Carmelo Rosa, Dr. Gang Wang, PhD, Dr. Gerald E Poly, Dr. Robert C Horan, MD, Dr. Yubing Tang, Dr. Zhihao Qiu (Peter), PhD, Dr. Zhou Chen (nmi), MD PhD, Edmund F Mrak, Jr, Eliezar Ramos, Elizabeth D Connell, Ellen P Madigan, Emest F Bizjak, Emily A Baldwin, Emily A Walters, Emmanuel Jramos Maldonado, Eric J Cunningham, Eric Rothschild, Erika E Englund, PhD, Erin D Mccaffery, Esteban Beltran, Felix Maldonado, Frank J Marciniak, Frank Wackes, Fred Razzaghi, Frederick F Razzaghi, Gabrielle J Swain, Gam S Zamil, Gary J Hagan, Gavin T Cua, George J Flynn, George Pyramides, Gerald B Seaborn, Jr, Geraldine D Sanders, German Rivera, Gianine E Delade, Gianine E Tompkins, Ginger M Sykes, Gobiga Vanniyasingam, Graeme E Price, Graeme Price, Guerlain Ulysse, Gwyn G Dickinson, Haitao Li, Hector Jcolon Torres, Helen B Ricalde, Helen Verdel, Himanshu Gupta, PhD, Holly Brevig, Iqra Iftikhar, Ivan E Reyes, Ivis L Negron, Jacob G Lutz, Jacqueline Mdiaz Albertini, Jacqueline S Warner, Jai P Singh, James A Liubicich, James C Maclaughlin, James I Giefer, James L Dunnie, Jr, James M Mason, James M Simpson, James Norman, James P Mcevoy, James R Birkenstamm, James R Evans, James W Plucinski, Janet A Rajan, Jason Kwong, Javier O Vega, Jawaid Hamid, Jay B Shah, Jay T Wong, Jean Blackston Hill, Jean M Kelahan, Jean M Mulinde, MD, Jeen S Min, Jeffery A Hangartner, Jeffrey A Sommers, Jeffrey J Ebersole, Jennifer C Johnson, Jennifer L Huntington, Jennifer M Gogley, Jenny Sung, Jesse A Vazquez, Jessica M Monteiro, Jessica S Estriplet, Jill Mielziner, Joan A Loreng, Joanne E King, Joey C West, Jogy George, John A Gonzalez, John A Podsadowski, John P Mistler, Johnna L Bleem, Jonathan G Matrisciano, Jonathan S Helfgott, Jonathan W Chapman, Jonee J Mearns, Jorge L Gonzalez, Jorge L Guadalupe, Jose A Lopez, Jose Acruz Gonzalez, José E Meléndez, Jose F Pedro, Jose M Cayuela, Jose Ohernandez Guzman, Jose R Hernandez, Jose Velez, Joseph A Piechocki, Joseph F Mcginnis, RPh, Josh Renzo N Ramilo, Joshua P Wireman, Joy Rkozlowski Klena, Juanita P Versace, Judith A Paterson, Julianne C Mccullough, Julie D Bringger, Junho Pak, Justin A Boyd, Justine M Corson, Justine Tomasso, Karen A Briggs, Karen A Spencer, Karen E D'orazio, Karen F Tomaziefski, Karen M Ferguson, Karishma G Gopaul, Karl D Hezel, Kassa Ayalew, MD, Katherine D Adams, Katherine Szestypalow, Kathleen M Jordan, Katie L Korchinski, Keith M Reilly, Kelli F Dobilas, Kelli Regente, Kenneth H Williams, Kenneth M Gordon, Kent C Faul, Kevin D Kallander, Kevin Obrien, Kevin P Foley, Kham Phommachanh, Kim Lthomas Cruse, Kinh Q Mac, Kip J Hanks, Ko U Min, Kristen E Rescigno, Kristina J Donohue, Kristina L Conroy, Kristy A Zielny, Kristy E Zuroski, Krystyna M Kitson, Kyle D Covill, Laishan L Lam, Laiza V Garcia, Larry K Austin, Lata C Mathew, PhD, Latorie S Jones, Laura Fontan, MS, Laurel A Beer, Lauren E Skokan, Lauren L Vajo, Lauren N Barber, Laurie B Frazier, Laurie Nelson, Laurimer Kuilan Torres, Lawrence Harmon, Jr, LCDR Debra Emerson, LCDR Matthew R Mcnew, MPH, REHS/RS, LCDR Michael H Tollon, LCDR Susan E Polifko, Leiyun Boone, PhD, Li Li, Li Yun Huang, Liatte Kreuger, PharmD, Libia M Lugo, Lily Y Koo, Linda F Murphy, Linda Thai, Lisa B Hall, Lisa Harlan, Lisa M Bellows, Lisa M Feola, Lloyd D Payne, Loretta Nemchik, Lori B Wikstrom, Lori J Silverstein, Lori M Newman, Lori Wikstrom, Lucas B Leake, Luella J Rossi, Luis A Carrion, Luis A Dasta, Lydia I Rosas Marty, Maan S Abduldayem, Makini Cobourne Duval, PhD, Manhar R Patel, Maotang Zhou, PhD, Marcellinus D Dordunoo, Marcelo O Mangalindan, Jr, Marcia Gelber, Marea K Harmon, Margaret M Annes, Margaret M Sands, Maria A Bienkowski, Maria A Reed, Maria Estrella, Maria Joselopez Barragan, PhD, Marie A Fadden, Marie B Buen Bigornia, Marie F Morin, Marion Michaelis, Mariza M Jafary, Marjorie A Shapiro, PhD, Mark E Parmon, Mark R Mcclain, Marlene G Swider, Maryam Tabatabaie, Matthew A Spataro, Matthew B Casale, Matthew C Watson, Matthew R Noonan, Maya M Davis, Mayar M Mussa, Megan A Haggerty, Melba Trivera Clavell, Melissa B Libby, Melissa J Garcia, Melissa T Roy, Meredith L Sheridan, Meyer J Slobotsky, Michael A Charles, Michael A Taylor, Michael E Maselli, Michael Gurbarg, Michael L Casner, Michael R Goga, Michael R Klapal, Michael Serrano, Michael Shanks, MS, Michael W Burd, Michele Gottshall, Michele L Glendenning, Michele L Obert, Michele Perry Williams, Miguel A Martinez Perez, Miguel Gmanzano Maldonado, Mihaela Jason, Mihaly S Ligmond, Milva E Melendez Perales, Mina D Ahmadi, Mindy M Chou, Minh D Phan, Miral B Patel, Mohsen Rajabi Abhari, FDA, Monica Commerford, PhD, Monika Borkowska, Mra B Kamberem, Mra Mcculloughj, Mra V Millarw, Muralidhara B Gavini, PhD, Myriam M Sosa, Nadeem I Chaudhry, Nailing Zhang, Nancy F Scheraga, Nancy G Schmidt, Nancy L Rolli, Nancy M Espinal, Natasha Gupta, Naveen B Kanthamneni, Nerizza B Guerin, Nibin Varghese, MS, Nicholas A Violand, Nicholas P Diorio, Nicholas Z Lu, Nicola M Fenty Stewart, Nicole E Knowlton, Niketa Patel, Nikisha M Bolden, Nikki S Ramirez, Nina Yang, Niraj R Mehta, PhD, Nirjal Bhattarai, Noreen Muñiz, Odera I Ekwunife, Omotunde O Osunsanmi, Pal S Mayasandra, Paola S Barnett, Paraluman S Leonin, Parul M Patel, Patricia A Mcilroy, Patricia F Hughes, PhD, Patrick C Klotzbuecher, Patsy J Domingo, Paul A Bonneau, Paul Mouris, Paula A Trost, Paula J Bretz, Peter Adams, PhD, Peter E Baker, Peter R Lenahan, Philip F Istafanos, DMV, MS, Phillip E Mclaughlin, Phillip O Mathis, Prabhu P Raju, Puspa Suresh Jayasekara, Qin Xu, Rachael O Oyewole, Rachel C Harrington, Raeann R Wu, Rafael Nevarez Nieves, Rajiv R Srivastava, Ralph A Erickson, Ramon A Hernandez, Ramon E Martinez, Raymond Kent, Raymond L Cheung, Raymond T Oji, Reba A Gates, Rebecca E Dombrowski, Rebecca Rodriguez, Regina T Brown, Remache, Reyes Candau Chacon, PhD, Richard A Abate, Richard E Needham, Richard Jay Tucker, RS, Richard K Vogel, Richard W Thornton, Robert C Coleman, Robert C Steyert, Robert D Tollefsen, Robert J Doyle, Robert J Martin, Robert Jennings, Robert O'brian, Robert Sharpnack, Robin P Mathew, Rochelle K Kimmel, Rochelle L Campbell, Rochelle L Cross, Rodney T Allnutt, Rory K Geyer, Rosario D'costa, Rose Ljean Mary, Rose Xu, Russell J Glapion, Sachinkumar V Patel, Saied A Asbagh, Saleem A Akhtar, Sam H Haidar, PhD, Samantha J Bradley, Samir C Gala, Samuel Mindaye, Sandra A Boyd, Sandra Kershaw, Santos E Camara, Sarah Adella Fave, Sarah Forney, Satheesh K Podaralla, Satheesh Thomas, Scott R Nichols, PhD, Sean G Casey, Sean R Marcsisin, Sena G Dissmeyer, Seneca D Toms, Sergio Chavez (NMI), Shafiq S Ahadi, Sharon K Thoma, PharmD, Sherri J Liu, Shirley H Isbill, Shirley S Wen, Sidney B Priesmeyer, Simone E Pitts, Sinai I Davis, Sixto M Mercado Rios, Sony Mathews, Sonya M Edmonds, Srinivas R Chennamaneni, PhD, Stacey S Degarmo, Stacie A Woods, Stephanie T Durso, Stephen D Brown, Stephen D Eich, Stephen J Koniers, Stephen J Mottola, Stephenie M Ortiz, Steven A Gonzales, Steven D Kehoe, Steven Frisbee, Suchan Kim, Susan F Laska, MS, Susan W Ting, Susanna E Ford, Suzanne N Vallez, Suzanne Vallez, Syeda N Mahazabin, Taichun Qin, PhD, Tamil Arasu, PhD, Tania E Garcia, Tania E Vizcaino, Tanya R Syffrard, Tara G Bizjak, Tara R Gooen, Ted L Anderson, Tekalign Wondimu, Temar Q Williams, Teresa I Navas, Thai D Truong, That Q Dang, Thomas E Friel, Thomas J Arista, Thomas R Withers, Thuy T Nguyen, LCDR, Tiffani D Wilson, Tina M Pawlowski, Tonia F Bernard, Towanda L Terrell, Toyin B Oladimeji, Travis R Hunt, Truong Xuan Nguyen (Andy), Tyanna N Hadley, Unnee Ranjan, Uttaniti Limchumroon (Tom), Valentino Fiorella, Valerie C Reed, Valerie L Whipp, Valerie Reed, Veronica Fuentes, MS, Victoria Spivak, Viviana R Ramirez, Vivin George, Wanda B Coats, Wayne E Seifert, Wayne J Meyer, Wayne T Smith, William Hallett, PhD, William J Leonard, William J Muszynski, William R Chang, Xiaohan Cai, PhD, Xiaokuang Lai, PhD, Xiaoping Guan, Xikui Chen (nmi), PhD, Yan Wang, Yeissa Chabrier Rosello, Ying Zhang, Yong Wu, PhD, Yoriann M Cabrera Bartolomei, Yumi J Hiramine, Yvesna C Blaise, Yvette I Henry, Yvette I Johnson, Yvins Dezan, Yvonne C Mcknight, Zachary A Bogorad, Zakaria I Ganiyu, Ze Peng, Zhaohui Ye, Zhijin Chen, Zhong Li, PhD, Zhongren Wu, Zi Qiang Gu

Paul L Bellamy's Documents

Publish Date Document Type Title
November, 2013 EIR Cosette Pharmaceuticals, Inc. - EIR, 2013-11-19
July, 2010 FDA 483 OHM LABORATORIES INC. - Form 483, 2010-07-14
February, 2002 FDA 483 Tri-Med Laboratories Inc - Form 483, 2002-02-21
July, 2000 FDA 483 GE Healthcare Inc. - Form 483, 2000-07-12
June, 2001 FDA 483 Janssen Pharmaceuticals Inc. - Form 483, 2001-06-28
May, 2012 EIR Avantor Performance Materials, LLC - EIR, 2012-05-11
January, 2012 EIR Cosette Pharmaceuticals, Inc. - EIR, 2012-01-12
September, 2012 EIR CURIA NEW JERSEY LLC - EIR, 2012-09-27
April, 2001 EIR P.E.L. Associates Inc - EIR, 2001-04-19
June, 2006 FDA 483 Guardian Drug Company - Form 483, 2006-06-12
April, 2011 FDA 483 Hikma Pharmaceuticals USA Inc. - Form 483, 2011-04-13
June, 2011 FDA 483 Sun Pharmaceutical Industries, Inc. - Form 483, 2011-06-28
October, 2015 FDA 483 SaveWay Compounding Pharmacy, Inc. - Form 483, 2015-10-02
June, 2015 EIR Primera Analytical Solutions Corporation - EIR, 2015-06-02
October, 2014 FDA 483 Tris Pharma Inc - Form 483, 2014-10-01
May, 2011 FDA 483 Akorn Operating Company LLC (dba Akorn) - Form 483, 2011-05-19
October, 2004 EIR Everest Life Sciences LLC - EIR, 2004-10-26
October, 2015 FDA 483 Amneal Pharmaceuticals, LLC - Form 483, 2015-10-16
October, 2003 FDA 483 Novartis Pharma Produktions GmbH - Form 483, 2003-10-09
August, 2001 EIR Actavis Elizabeth LLC - EIR, 2001-08-17
January, 2000 FDA 483 Response Janssen Pharmaceuticals, Inc. - Form 483R, 2000-01-28
March, 2004 EIR Merck & Co., Inc. - EIR, 2004-03-09
November, 2016 FDA 483 InvaTech Pharma Solutions LLC - Form 483, 2016-11-08
October, 2010 FDA 483 Hikma Pharmaceuticals USA Inc. - Form 483, 2010-10-29
September, 2002 FDA 483 Response Bayer Aktiengesellschaft - Form 483R, 2002-11-15
March, 2017 EIR Amneal Pharmaceuticals LLC - EIR, 2017-03-20
October, 2000 EIR Nelson Laboratories Fairfield Inc. - EIR, 2000-10-02
April, 2001 EIR Actavis Totowa LLC - EIR, 2001-04-11
May, 2000 FDA 483 Response Glaxo Smithkline - Form 483R, 2000-05-19
August, 2000 FDA 483 Sandoz Inc. - Form 483, 2000-08-08
July, 2008 EIR Sonar Products, Inc. - EIR, 2008-07-22
November, 2011 FDA 483 Aurolife Pharma LLC - Form 483, 2011-11-02
October, 2014 FDA 483 Amneal Pharmaceuticals LLC - Form 483, 2014-10-23
March, 2015 EIR ScinoPharm Taiwan, Ltd. - EIR, 2015-03-27
May, 2001 EIR Renaissance Lakewood LLC - EIR, 2001-05-03
January, 2014 EIR Appco Pharma LLC - EIR, 2014-01-16
August, 2002 EIR Organon USA Inc. - EIR, 2002-08-23
February, 2002 FDA 483 Avantor Performance Materials, LLC - Form 483, 2002-02-01
June, 2016 FDA 483 Village Pharmacy - Form 483, 2016-06-22
June, 2005 EIR Hikma Pharmaceuticals USA, Inc. - EIR, 2005-06-08
June, 2003 EIR Pliva, Inc. - EIR, 2003-06-20
April, 2014 EIR Infinity Labs NJ, LLC - EIR, 2014-04-11
November, 2015 FDA 483 Cetylite Industries, Inc. - Form 483, 2015-11-19
May, 2001 EIR Hikma Pharmaceuticals USA Inc. - EIR, 2001-05-21
September, 2009 FDA 483 Merck, Inc. - Form 483, 2009-09-01
April, 2001 EIR Alcami Corporation - EIR, 2001-04-02
October, 2015 EIR Amneal Pharmaceuticals, LLC - EIR, 2015-10-16
September, 2001 EIR Bayer Oy - EIR, 2001-09-26
August, 2000 EIR Contract Coating Inc. - EIR, 2000-08-17
March, 2004 FDA 483 Merck, Inc. - Form 483, 2004-03-09
April, 2008 FDA 483 Response ENDO USA, Inc. - Form 483R, 2008-05-08
March, 2000 FDA 483 Response Merck Sharp & Dohme LLC - Form 483R, 2000-05-05
December, 2015 EIR The Jet Pulverizer Company - EIR, 2015-12-21
November, 2010 EIR The Jet Pulverizer Company - EIR, 2010-11-08
March, 2001 EIR Organon USA Inc. - EIR, 2001-03-15
June, 2003 FDA 483 Pliva, Inc. - Form 483, 2003-06-20
February, 2002 EIR Avantor Performance Materials, LLC - EIR, 2002-02-01
July, 2002 FDA 483 Novartis Pharmaceuticals Corporation - Form 483, 2002-07-19
March, 2013 FDA 483 Biogen, Inc. - Form 483, 2013-03-15
October, 2003 FDA 483 Holopack-Verpackungstechnik-GmbH - Form 483, 2003-10-16
October, 2001 FDA 483 FAR Specialty Products, Inc. - Form 483, 2001-10-19
May, 2016 FDA 483 Response Navinta LLC - Form 483R, 2016-06-06
July, 2011 EIR Johnson & Johnson Consumer Inc. - EIR, 2011-07-22
July, 2000 EIR GE Healthcare Inc. - EIR, 2000-07-12
February, 2015 FDA 483 CMIC CMO USA CORP - Form 483, 2015-02-13
September, 2002 EIR Bayer AG - EIR, 2002-09-19
March, 2000 EIR Renaissance Lakewood LLC - EIR, 2000-03-29
March, 2004 FDA 483 Response Merck, Inc. - Form 483R, 2004-04-06
April, 2012 EIR Primera Analytical Solutions Corporation - EIR, 2012-04-27
November, 2002 FDA 483 Micro Chem Laboratories - Form 483, 2002-11-22
September, 2007 EIR SGS North America Inc. - EIR, 2007-09-12
May, 2008 FDA 483 Response Sun Pharmaceutical Industries, Inc. - Form 483R, 2008-08-08
March, 2003 FDA 483 The P.F. Laboratories Inc. - Form 483, 2003-03-27
February, 2015 FDA 483 Response CMIC CMO USA CORP - Form 483R, 2015-03-06
October, 2015 FDA 483 Response Amneal Pharmaceuticals, LLC - Form 483R, 2015-10-16
September, 2003 FDA 483 Sonar Products, Inc. - Form 483, 2003-09-17
August, 2004 EIR Veranova, L.P. - EIR, 2004-08-19
April, 2008 FDA 483 ENDO USA, Inc. - Form 483, 2008-04-22
April, 2008 EIR Loricon Testing Service, Inc. - EIR, 2008-04-09
June, 2013 EIR ACINO PRODUCTS LIMITED LIABILITY COMPANY - EIR, 2013-06-13
September, 2002 EIR Bayer Aktiengesellschaft - EIR, 2002-09-19
February, 2014 EIR Hikma Pharmaceuticals USA, Inc. - EIR, 2014-02-26
June, 2003 FDA 483 Response Pliva, Inc. - Form 483R, 2003-07-08
September, 2014 EIR UQUIFA Mexico, S.A. de C.V. - EIR, 2014-09-12
May, 2000 FDA 483 Glaxo Smithkline - Form 483, 2000-05-04
November, 2003 EIR Spray-Tek, Inc. - EIR, 2003-11-14
April, 2008 EIR ENDO USA, Inc. - EIR, 2008-04-22
January, 2000 FDA 483 Janssen Pharmaceuticals, Inc. - Form 483, 2000-01-21
May, 2017 EIR Akorn Operating Company LLC (dba Akorn) - EIR, 2017-05-12
August, 2011 FDA 483 Tris Pharma Inc - Form 483, 2011-08-16
June, 2009 EIR Akorn Operating Company LLC (dba Akorn) - EIR, 2009-06-12
September, 2002 FDA 483 Response Bayer AG - Form 483R, 2002-11-15
September, 2010 FDA 483 Rasi Laboratories, Inc. - Form 483, 2010-09-03
March, 2009 FDA 483 Hikma Pharmaceuticals USA Inc. - Form 483, 2009-03-10
March, 2012 FDA 483 Renaissance Lakewood LLC - Form 483, 2012-03-09
December, 2001 FDA 483 Hoffmann La Roche Inc - Form 483, 2001-12-12
March, 2012 EIR Renaissance Lakewood LLC - EIR, 2012-03-07
October, 2008 EIR Primera Analytical Solutions Corporation - EIR, 2008-10-28
May, 2016 FDA 483 Navinta LLC - Form 483, 2016-05-16
October, 2001 EIR FAR Specialty Products, Inc. - EIR, 2001-10-19
March, 2011 FDA 483 Teligent, Inc. - Form 483, 2011-03-08
May, 2001 FDA 483 Hikma Pharmaceuticals USA Inc. - Form 483, 2001-05-21
September, 2000 FDA 483 Patheon Toronto Regional Operations - Form 483, 2000-09-20
January, 2001 FDA 483 Hoffmann-La Roche Inc. - Form 483, 2001-01-31
August, 2002 FDA 483 Organon USA Inc. - Form 483, 2002-08-23
September, 2000 EIR Patheon Inc. - EIR, 2000-09-20
February, 2014 FDA 483 Hikma Pharmaceuticals USA, Inc. - Form 483, 2014-02-26
October, 2003 FDA 483 Response Novartis Pharma Produktions GmbH - Form 483R, 2003-10-24
December, 2006 EIR OHM LABORATORIES INC. - EIR, 2006-12-21
February, 2017 FDA 483 Novel Laboratories, Inc. - Form 483, 2017-02-14
April, 2009 EIR Changzhou Pharmaceutical Factory - EIR, 2009-04-02
May, 2000 EIR Glaxo Smithkline - EIR, 2000-05-04
January, 2001 FDA 483 Response Hoffmann La Roche Inc - Form 483R, 2001-02-21
January, 2017 EIR Janssen Pharmaceuticals Inc. - EIR, 2017-01-26
March, 2006 EIR Glaxo Wellcome Production - EIR, 2006-03-10
September, 2006 FDA 483 Sunrise Pharmaceutical Inc - Form 483, 2006-09-19
April, 2016 FDA 483 Keystone Industries - Form 483, 2016-04-05
December, 2001 EIR Hoffmann La Roche Inc - EIR, 2001-12-12
October, 2013 FDA 483 Aurolife Pharma LLC - Form 483, 2013-10-15
May, 2002 EIR Halo Pharmaceuticals Inc. - EIR, 2002-05-02
July, 2002 EIR Novartis Pharmaceuticals Corporation - EIR, 2002-07-19
May, 2003 EIR Pliva, Inc. - EIR, 2003-06-25
April, 2001 FDA 483 P.E.L. Associates Inc - Form 483, 2001-04-19
September, 2000 FDA 483 Response Patheon Inc. - Form 483R, 2000-10-19
December, 2003 EIR Equistar Chemicals, LP - EIR, 2003-12-16
June, 2001 EIR Janssen Pharmaceuticals Inc. - EIR, 2001-06-28
January, 2001 EIR Hoffmann La Roche Inc - EIR, 2001-01-31
June, 2002 FDA 483 FAR Specialty Products, Inc. - Form 483, 2002-06-26
October, 2003 EIR Holopack-Verpackungstechnik-GmbH - EIR, 2003-11-17
August, 2014 EIR Appco Pharma LLC - EIR, 2014-08-21
October, 2003 EIR Novartis Pharma Produktions GmbH - EIR, 2003-11-17
March, 2000 FDA 483 Merck Sharp & Dohme LLC - Form 483, 2000-03-16
September, 2001 FDA 483 Response Bayer Oy - Form 483R, 2001-10-31
March, 2000 EIR Merck Sharp & Dohme LLC - EIR, 2000-03-16
March, 2004 EIR Merck, Inc. - EIR, 2004-03-09
January, 2000 EIR Janssen Pharmaceuticals, Inc. - EIR, 2000-01-21
January, 2016 EIR Teligent, Inc. - EIR, 2016-01-22
June, 2017 EIR SOFIE Co. dba SOFIE - EIR, 2017-06-28
March, 2001 FDA 483 Organon USA Inc. - Form 483, 2001-03-15

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more